OpGen, Inc. Form 8-K Filing

2025-12-23SEC Filing 8-K (0001829126-25-010286)

This Form 8-K filing by OpGen, Inc. details amendments to a Securities Purchase Agreement with AEI Capital Ltd. Initially entered into on August 22, 2024, for up to $3.0 million, the agreement was amended on October 3, 2024, to allow for two additional tranches of $3.0 million each, totaling $9.0 million, and extended the selling period to December 31, 2025. A further amendment via a Supplemental Letter on December 17, 2025, extended the selling period to December 31, 2026. The filing also notes the unregistered sale of equity securities under exemptions from the Securities Act of 1933. Additionally, David Lazar resigned as President, effective January 8, 2026. The filing includes exhibits related to the Supplemental Letter and the Cover Page Interactive Data File.

Ticker mentioned:OPGN